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Abstract
Diabetes mellitus type 2 (DMT2) is a prevalent disease that affects many people throughout the
world leading to issues such as diabetic cardiomyopathy. O-GlcNAcylation dysregulation,
caused by increased levels of serum glucose, contributes to the pathophysiology of decreased
cardiac function. O-GlcNAcylation modulates cardiac contraction by reacting with either serine
or threonine residues. Our goal was to demonstrate the success of infection of adeno-associated
virus 9 (AAV9) carrying the gene of alpha-cardiac actin (ACTC) mutated at Thr326. Here we
show the expression of the mutant ACTC T326D in H9C2 cardiomyoblasts and HEK293T cell
lines. Expression in H9C2 cells was significantly increased compared to WT and control. In
addition, expression in HEK293T cells was significantly increased compared to the control.
These results are promising in that the ACTC gene carried in AAV9 can be transduced into cells
in diabetic mouse model to prevent O-GlcNAcylation and improve cardiac contractility.
Introduction

DMT2 is a metabolic disorder caused by hyperglycemia due to β islet cells being unable to
secrete adequate insulin in response to varying degrees of overnutrition, inactivity, leading to
being overweight or obese, and insulin resistant [1]. In 2010, the worldwide prevalence of
diabetes was 285 million and is predicted to rise [1]. People with diabetes have an up to fivefoldhigher risk for a first myocardial infarction, and also have 2 to 4 times higher mortality rates due
to heart disease compared to the general population [2]. Cardiac risks common in patients with
diabetes such as hypertension, dyslipidemia, and atherosclerosis further compromise cardiac
function. Diabetic cardiomyopathy can be described as progressive diastolic and systolic
dysfunction in addition to structural changes independently caused by diabetes [3].
Since blood glucose is one of the most characteristic markers in diabetes, its presence can affect
the normal function of proteins. The high concentration of glucose can dysregulate the flux of it
in the hexosamine biosynthetic pathway (HBP), leading to high concentration of Nacetylglucosamine. This molecule is known to act as a post-translational modification called O-

GlcNAcylation where the N-Acetylglucosamine reacts with Threonine and Serine residues. OGlcNAcylation, when not regulated, contributes to the etiology of diabetes by blocking insulin
signaling at multiple points [4]. Increased levels of glucose, as seen with diabetics, have been
shown to increase the O-GlcNAcylation of proteins in the insulin-secreting pancreatic β cells [4].
The excess of O-GlcNAcylation in diabetes contributes to cardiac dysfunction, reduction of the
levels of O-GlcNAcylation could be a beneficial effect on the diabetic cardiac function [5].
In this work, we corroborate the efficiency of infection of AAV9 which carries the alpha cardiac
actin gene with a mutation in Thr326 in two different cell lines. These AAV can be used for the
transduction of the alpha-cardiac actin gene in the heart, reducing the possibility to be Oglycosylated in a mouse model of DMT2, such as Ob/Ob strain.
Material and Methods
Cell culture and virus transduction
HEK293T cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10%
fetal bovine serum, 50 U/ml penicillin, and 50 g/ml streptomycin in 5% CO2 air equilibrated. 37
°C incubator. H9C2 cells were cultured in same conditions as the HEK293T. AAV9
(1x1012GC/ml) carrying the mutated or a wild type alpha-cardiac actin gene were transduced
using polybrene (10 µg/ml).
Western Blot
H9C2 and HEK293T cells expressing actin T326D, WT actin infected with AAV-9 were
homogenized in RIPA buffer (Thermo Fisher Scientific) with protease inhibitors cocktail
(Roche). After a brief centrifugation, the supernatant was kept, and protein concentration
determined by the Bradford method (Pierce™ Coomassie (Bradford) Protein Assay Kit) as
described by the manufacturer with Bovine Serum Albumin (BSA) as a standard. Samples were
denatured and equal amounts of protein were subjected to Polyacrylamide gel electrophoresis
(PAGE) at 200V for 30 min and electrotransferred to Polyvinylidene fluoride (PVDF).
Membranes were then blocked with 5% BSA solution and incubated overnight with antibody
against alpha-cardiac actin (Invitrogen PA5-21396). The detection of GAPDH (Cell Signaling
#2118) was used as a loading control Peroxidase-conjugated anti-rabbit (Cell Signaling, #7070).
Bands were visualized with enhanced chemiluminescence reagent (SuperSignal West Pico PLUS
Chemiluminescent Substrate, Thermo Fisher Scientific) and iBright (Thermo Fisher Scientific)
and quantified using Image J analysis software.
Statistical analysis
Data are expressed as means ± SEM. One-way ANOVA test followed by Student-NewmanKeuls were used when appropriate. P value < 0.05 was considered of statistical significance.

Results and Discussion
The expression of the ACTC was evaluated in the HEK293T and H9C2 cells by Western Blot.
As shown in Fig. 1A-B, the expression of ACTC was significantly increased in the mutant
compared to the WT and control. Results from Fig. 1C-D show that the expression of ACTC was
significantly increased in the mutant compared to the control only.

Fig. 1. ACTC expression in H9C2 and HEK293T cell lines measured by Western Blot. A. ACTC and GAPDH protein expression in
H9C2 cardiomyoblast cells. B. Representative western blot for the expression of ACTC and GAPDH in H9C2 cardiomyoblast cells.
C. ACTC and GAPDH protein expression in HEK293T cells. D. Representative western blot for the expression of ACTC and
GAPDH in HEK293T cell line. Bars represent mean ± SEM, the number of individual experiments for each group is depicted inside
bars. * Correspond to p < 0.05 One-way ANOVA analysis

The main finding in this experiment is the efficiency of AAV carrying the alpha actin gene
T326D mutation in two different cell lines. We will continue doing further experiments assessing
the effect of alpha-cardiac gene mutations on myofilament contraction in an animal model of
diabetes.
Information from these experiments may help us understand better how increased serum glucose
levels in diabetic patients’ affects heart contractility leading to diabetic cardiomyopathy. More

specifically, in the cardiac-alpha actin protein, which is an important player during excitationcontraction coupling.
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